Status:
UNKNOWN
Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients
Lead Sponsor:
Assiut University
Conditions:
Severe Aplastic Anemia
Eligibility:
All Genders
16-50 years
Phase:
PHASE2
PHASE3
Brief Summary
Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia and marrow hypoplasia.The theoretical basis for marrow failure includes primary defects in or damage to th...
Detailed Description
The distinction between acquired and inherited disease may present a clinical challenge, but more than 80% of cases are acquired. Therapy for aplastic anemia may consist of supportive care only, immu...
Eligibility Criteria
Inclusion
- All patients with severe and very severe aplastic anemia for stem cell therapy.
Exclusion
- 1- Contraindication to stem cell transplantation. 2 - Patients associated co-morbidities.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03295058
Start Date
January 1 2019
End Date
June 1 2020
Last Update
November 27 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.